Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma-Reference-Cited by-同舟云学术

Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma

Published:2017-04-03 Issue:4 Volume:12 Page:e0174835
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Beldi-Ferchiou Asma^ORCID,Skouri Nour,Ben Ali Cyrine,Safra Ines,Abdelkefi Abderrahman,Ladeb Saloua,Mrad Karima,Ben Othman Tarek,Ben Ahmed Mélika

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Multiple myeloma;RA Kyle;N Engl J Med,2004

2. Multiple myeloma;J Blade;Ann Oncol,2010

3. Multiple myeloma;RA Kyle;Blood,2008

4. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy;C Chung;Pharmacotherapy,2016

5. Improved survival in multiple myeloma and the impact of novel therapies;SK Kumar;Blood,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism study of tyrosine phosphatase shp-1 in inhibiting hepatocellular carcinoma progression by regulating the SHP2/GM-CSF pathway in TAMs;Scientific Reports;2024-04-21

2. β-adrenergic modulation of IL-6/gp130 and SOCS-1 in multiple myeloma: therapeutic strategy for stress induced-inflammatory response;memo - Magazine of European Medical Oncology;2024-02-09

3. Euphorbiasteroid Induces Apoptosis as Well as Autophagy through Modulating SHP-1/STAT3 Pathway in Hepatocellular Carcinoma Cells;International Journal of Molecular Sciences;2023-09-05

4. Genetic Abnormalities in Extramedullary Multiple Myeloma;International Journal of Molecular Sciences;2023-07-09

5. Characterization of monoclonal gammopathy of undetermined significance progression to multiple myeloma through meta-analysis of GEO data;Heliyon;2023-07